MOUNTAIN VIEW, Calif., April 14 /PRNewswire/ -- Aviron (Nasdaq: AVIR)
today announced Charlene A. Friedman has been named Vice President and General
Counsel. In this newly created position, Ms. Friedman will be responsible for
all legal matters affecting the company and will oversee Aviron's internal
legal team.
Throughout her nearly 18 year legal career, Ms. Friedman has served as
both a corporate attorney and a litigator. She joins Aviron from Collagen
Aesthetics, Inc., where she served as Vice President, Legal and Regulatory
Affairs, General Counsel and Assistant Secretary. In this role, she was
responsible for legal issues, including licensing and contracts, litigation,
intellectual property, SEC filings and compliance. Prior to joining Collagen
Aesthetics, Ms. Friedman served as an attorney with Lillick & Charles in
San Francisco and Warner & Stackpole in Boston.
"Charlene's depth of experience in legal and regulatory matters will
provide Aviron with a much needed skill set. The addition of a General
Counsel to our management team is another important step in growing the
operational infrastructure we need as we move closer to the commercialization
of FluMist(TM)," said C. Boyd Clarke, Aviron President and Chief Executive
Officer.
Ms. Friedman earned her J.D. from Northeastern University School of Law
and graduated magna cum laude from Tufts University.
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
Actual results may differ materially from the forward-looking statements
contained in this release. Factors that could cause actual results to differ
include, but are not limited to, failure to validate the manufacturing
process, facilities or equipment for the company's nasal influenza vaccine,
and the assessment by regulatory agencies that the company's future license
applications for its nasal influenza vaccine are incomplete or inadequate to
approve the product for marketing to one or more target populations.
Additional information concerning factors that could cause such a difference
is contained in Aviron's SEC filings, including its S-3 Registration Statement
and Annual Report on Form 10-K for the year ended December 31, 1999.
To receive an index and copies of recent press releases, call Aviron's
News-On-Call toll-free fax service, 800-758-5804, extension 114000.
Additional information about the company can be located at
http://www.aviron.com.
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html or fax,
800-758-5804, ext. 114000
CONTACT:
John Bluth, 650-919-3716, or Fred Kurland,
650-919-6666, both of Aviron; or Claudette Hibbert, of
Fleishman-Hillard, 212-453-2000, for Aviron
|
